The influence of smoking on uterine bleeding during sequential oral hormone therapy

Climacteric

Volumn 10, Issue 2, 2007, Pages 147-154

  Bjarnason, N H ^a,d   Byrjalsen, I ^b   Jorgensen H L ^c   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b NORDIC BIOSCIENCE A S   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endometrium; Estrogen; Gestodene; Levonorgestrel; Smoking; Uterine bleeding

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; GESTAGEN; GESTODENE; LEVONORGESTREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HORMONE METABOLISM; HUMAN; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; UTERUS BLEEDING;

ADMINISTRATION, ORAL; CONTRACEPTIVE AGENTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEVONORGESTREL; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; SMOKING; UTERINE HEMORRHAGE;

EID: 33947592968     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701258820     Document Type: Article

References (16)

1. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J. Initial 17beta-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726-31
2. Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985;313:973-5
3. Bjarnason NH, Christiansen C. The influence of thinness and smoking on bone loss and response to HRT in early postmenopausal women. J Clin Endocrinol Metab 2000;85:590-6
4. Bjarnason NH, Jørgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral estrogen-progestogen therapy. Climacteric 2004;7:390-6
5. Andersen FS, Transbol I, Christiansen C. Is cigarette smoking a promotor of the menopause? Acta Med Scand 1982;212:137-9
6. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-70
7. Cornuz J, Feskanich D, Willett WC, Colditz GA. Smoking, smoking cessation and risk of hip fracture in women. Am J Med 1999;106:311-14
8. Terry PD, Rohan TE, Franceschi S, Weiderpass E. Cigarette smoking and the risk of endometrial cancer. Lancet Oncol 2002;3:470-80
9. Byrjalsen I, Haarbo J, Christiansen C. Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy. Obstet Gynecol 1993;81:1016-21
10. Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C. Serum lipids, lipoproteins and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates. Am J Med 1991;90:584-9
11. Bjarnason NH, Byrjalsen I, Hassager C, Haarbo J, Christiansen C. Low dose estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am J Obstet Gynecol 2000;183:550-60
12. Byrjalsen I, Thormann L, Meinecke B, Riis BJ, Christiansen C. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy. Hum Reprod 1992;7:1042-7
13. Byrjalsen I, Bjarnason NH, Christiansen C. Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy. Am J Obstet Gynecol 1999;180:539-49
14. Utian WH, Gass ML, Pickar JH. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women. Menopause 2004;11:306-14
15. Ma Q, Lu AY. Origins of individual variability in P4501A induction. Chem Res Toxicol 2003;16:249-60
16. Bjarnason NH. Drug metabolism and variability. N Engl J Med 2005;353:955-6